Dubai is to host the Middle East’s first dedicated exhibition and summit devoted to the digital technology driven precision medicine (PM) field this month.
More than 70 international experts, thought leaders and medical pioneers from Asia, the Middle East, Europe, and the US, are due to deliver incisive insights into the new methodology which is moving healthcare from a ‘one size fits all’ to a targeted, personalised, approach.
The newly-launched Precision Medicine Exhibition & Summit is being held under the patronage of Sheikh Nahyan bin Mubarak Al Nahyan, Minister of Tolerance and Coexistence and President of UAE Genetic Diseases Association.
The new event, which will be held at the Conrad Hotel from May 24 to 25, comes as global data and insights firm Netscribes projects the Middle East and Africa precision medicine market to expand at a compound annual growth rate of 10 percent to a revenue worth of $2.51 billion (AED9.2 billion) by 2023.
Founder and Chairperson of the UAE Genetic Diseases Association, Dr Maryam Matar, said: “Personalised medicine is certainly transforming the healthcare ecosystem for the better, driven by digitalisation and a rapidly rising corpus of knowledge that is redefining how we perceive the very nature of the origins and development of fatal diseases.”
Dubai’s Mohammed Bin Rashid University of Medicine and Health Sciences (MBRU) and the King Faisal Specialist Hospital and Research Centre in Saudi Arabia have established biomedical and genomics research centres and others expected to follow.
At the Precision Medicine Summit, healthcare providers, academic scientists and industry experts will have a uniquely focused opportunity to share knowledge, discuss challenges and opportunities.
CEO of Dubai Healthcare Corporation at the Dubai Health Authority, Dr Younis Kazim, said” “With the use of technological developments such as artificial intelligence and machine learning, precision medicine allows doctors and researchers to accurately predict which treatment and prevention methods for a certain disease will work in which groups of patients.
“As well as helping to bolster the UAE’s overall healthcare technology development, we are optimistic that the event will have a significant impact on how we treat diseases – ultimately leading to better, and more cost-effective, personalised treatment programmes.”
Follow us on
